Role of inflammatory markers in polycystic ovaries syndrome: In relation to insulin resistance
- PMID: 33522094
- DOI: 10.1111/jog.14684
Role of inflammatory markers in polycystic ovaries syndrome: In relation to insulin resistance
Abstract
Objective: To evaluate the relationship between plasma levels of the inflammatory markers tumor necrosis factor-alpha (TNF-α), C reactive protein (CRP), and interlukin-6 (IL-6) with insulin resistance in Saudi women with polycystic ovaries syndrome (PCOS).
Methods: One hundred eighty Saudi women with and without PCOS, aged 22-38 years, were randomly recruited in this age and body mass index matched case-control study. Clinical assessment, anthropometric measurements, and biochemical parameters were determined for all study participants.
Results: Levels of TNF-α, IL-6, hs-CRP, insulin, and insulin resistance indices were significantly higher among PCOS group than their age and BMI matched controls (p < 0.05). Results showed that only QUICK-I (β = -0.247, p < 0.0001, 95% CI: -3.009 to -0.977) independently predicted TNF-α levels after adjustment for potential confounders.
Conclusions: Elevated plasma levels of TNF- α and IL-6 among PCOS women reflects a state of chronic inflammation with potential implication for insulin resistance, independent of obesity.
Keywords: HOMA-IR; IL-6; QUICKI; TNF-α; hs-CRP.
© 2021 Japan Society of Obstetrics and Gynecology.
Similar articles
-
Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.Dis Markers. 2009;26(4):163-70. doi: 10.3233/DMA-2009-0627. Dis Markers. 2009. PMID: 19729797 Free PMC article.
-
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19. Gynecol Endocrinol. 2014. PMID: 25137507
-
Impact of interlukin-6 on central obesity measures in women with polycystic ovarian syndrome.J Obstet Gynaecol. 2020 Nov;40(8):1133-1137. doi: 10.1080/01443615.2019.1697219. Epub 2020 Mar 11. J Obstet Gynaecol. 2020. PMID: 32157932
-
The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.Gynecol Endocrinol. 2015 Mar;31(3):225-8. doi: 10.3109/09513590.2014.976546. Epub 2014 Nov 6. Gynecol Endocrinol. 2015. PMID: 25373529
-
Chronic Low Grade Inflammation in Pathogenesis of PCOS.Int J Mol Sci. 2021 Apr 6;22(7):3789. doi: 10.3390/ijms22073789. Int J Mol Sci. 2021. PMID: 33917519 Free PMC article. Review.
Cited by
-
Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome.Int J Mol Sci. 2021 Apr 10;22(8):3923. doi: 10.3390/ijms22083923. Int J Mol Sci. 2021. PMID: 33920227 Free PMC article. Review.
-
The Association Between Increment of Interleukin-1 and Interleukin-6 in Women with Polycystic Ovary Syndrome and Body Mass Index.J Reprod Infertil. 2023 Jan-Mar;24(1):26-34. doi: 10.18502/jri.v24i1.11906. J Reprod Infertil. 2023. PMID: 36919048 Free PMC article.
-
Evaluation of systemic immune-inflammation index for predicting late-onset fetal growth restriction.Arch Gynecol Obstet. 2024 Jul;310(1):433-439. doi: 10.1007/s00404-024-07453-x. Epub 2024 Mar 27. Arch Gynecol Obstet. 2024. PMID: 38536449
-
The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging.Biomedicines. 2023 Oct 5;11(10):2711. doi: 10.3390/biomedicines11102711. Biomedicines. 2023. PMID: 37893085 Free PMC article. Review.
-
Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome.Mol Hum Reprod. 2024 Apr 30;30(5):gaae015. doi: 10.1093/molehr/gaae015. Mol Hum Reprod. 2024. PMID: 38603629 Free PMC article.
References
-
- Carmina E, Rosato F, Janno A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91:2-6.
-
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
-
- Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165-74.
-
- Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr. 2004;23:963-74.
-
- Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):1048-58.e1-2.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous